Quick Answer
Vivani Medical, Inc. reported Net Income Loss of -$26.61 million for the year ending 2025.
- Vivani Medical, Inc. showed a decrease of -13.3% in Net Income Loss from 2024 to 2025.
- This data is from Vivani Medical, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2017: -$6.84 million | Q3 2017: -$6.72 million | Q4 2017: -$7.41 million | Q1 2018: -$9.75 million | Q2 2018: -$7.96 million | Q3 2018: -$8.52 million | Q4 2018: -$8.86 million | Q1 2019: -$9.70 million | Q2 2019: -$8.44 million | Q3 2019: -$7.58 million | Q4 2019: -$7.87 million | Q1 2020: -$8.89 million | Q2 2020: -$3.10 million | Q3 2020: -$1.60 million | Q4 2020: -$1.29 million | Q1 2021: -$2.99 million | Q2 2021: -$2.68 million | Q3 2021: -$3.49 million | Q4 2021: -$1.28 million | Q1 2022: -$3.92 million | Q2 2022: -$4.10 million | Q3 2022: $1.42 million | Q1 2023: -$6.32 million | Q2 2023: -$6.53 million | Q3 2023: -$6.78 million | Q1 2024: -$6.04 million | Q2 2024: -$5.36 million | Q3 2024: -$6.04 million | Q1 2025: -$6.30 million | Q2 2025: -$7.14 million | Q3 2025: -$6.53 million.
- Over the full 13 years of available data (2013 to 2025), Vivani Medical, Inc.'s Net Income Loss has declined by 15.8%.
- Historical annual values: Fiscal year 2025: -$26.61 million | Fiscal year 2024: -$23.49 million | Fiscal year 2023: -$25.65 million | Fiscal year 2022: -$13.89 million | Fiscal year 2021: -$12.77 million | Fiscal year 2020: -$14.88 million | Fiscal year 2019: -$33.59 million | Fiscal year 2018: -$35.09 million | Fiscal year 2017: -$28.52 million | Fiscal year 2016: -$33.18 million | Fiscal year 2015: -$20.02 million | Fiscal year 2014: -$35.20 million | Fiscal year 2013: -$22.97 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: